<p>External Ventricular Drainage (EVD) is essential in managing intracranial hypertension, but the high costs of prefabricated systems limit access in low- and middle-income countries (LMICs). Handmade alternatives have emerged as low-cost options, though evidence of their safety and effectiveness remains limited. This study assessed the clinical performance of handmade EVDs through a retrospective cohort analysis and a literature review. We conducted a retrospective cohort study at Hospital Nacional Daniel Alcides Carrión (Callao (Lima Metropolitan Area), Peru) from January 2021 to April 2023. Twenty-three patients received either Prefabricated (<i>n</i> = 12) or Improvised (<i>n</i> = 11) EVDs. Outcomes included central nervous system (CNS) infection and device replacement. Statistical analysis included bivariate and multivariable logistic regression. Additionally, a systematic literature search identified seven studies from Spain, Tunisia, Nigeria, USA/UK, Philippines, Nepal, and Ethiopia reporting on handmade EVDs. In the Peruvian cohort, CNS infections occurred in 6/12 (50.0%) prefabricated EVD cases and 4/11 (36.4%) handmade EVD cases (<i>p</i> = 0.51), and replacement was required in 5/12 versus 3/11 cases (<i>p</i> = 0.47). In multivariable logistic regression, improvised EVD use was not significantly associated with CNS infection (aOR = 0.70; 95% CI: 0.07–6.63). In the literature review (7 publications; 317 patients), handmade EVDs were assembled using accessible materials (e.g., feeding tubes and urinary bags), with costs ranging from &lt;US$5 to €20 versus ~€485 for commercial devices, and reported heterogeneous but broadly comparable complication profiles. Including our cohort, the total evidence base comprised 340 patients. Handmade EVDs appear feasible and substantially less costly than prefabricated systems. In this small retrospective cohort, we did not detect a clear signal of increased infection or replacement compared with commercial EVDs, but estimates were imprecise and do not establish equivalence. Handmade systems may serve as a temporary bridging option when commercial kits are unavailable, pending prospective validation and standardized protocols.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Handmade external ventricular drainage in resource-limited settings: safety, feasibility, and cost-effectiveness from a Peruvian cohort and global evidence review

  • Fritz Fidel Váscones-Román,
  • Jason Riveros-Ruiz,
  • Lynn A. Quintana-Garcia,
  • Martin Alonso Hemeryth-Rengifo,
  • Wagner Rios-Garcia,
  • Jack Váscones-Román,
  • Gonzalo Jair Callahuanca-Flores,
  • Aryan Wadhwa,
  • Ana M. Ulloa-Cavero,
  • Nora Itusaca,
  • Dayanne Liviac,
  • Saríah M. Flores,
  • Victoria E. Butrón-Verástegui,
  • Daniela Limbania,
  • John D. Rolston,
  • Niels Pacheco-Barrios

摘要

External Ventricular Drainage (EVD) is essential in managing intracranial hypertension, but the high costs of prefabricated systems limit access in low- and middle-income countries (LMICs). Handmade alternatives have emerged as low-cost options, though evidence of their safety and effectiveness remains limited. This study assessed the clinical performance of handmade EVDs through a retrospective cohort analysis and a literature review. We conducted a retrospective cohort study at Hospital Nacional Daniel Alcides Carrión (Callao (Lima Metropolitan Area), Peru) from January 2021 to April 2023. Twenty-three patients received either Prefabricated (n = 12) or Improvised (n = 11) EVDs. Outcomes included central nervous system (CNS) infection and device replacement. Statistical analysis included bivariate and multivariable logistic regression. Additionally, a systematic literature search identified seven studies from Spain, Tunisia, Nigeria, USA/UK, Philippines, Nepal, and Ethiopia reporting on handmade EVDs. In the Peruvian cohort, CNS infections occurred in 6/12 (50.0%) prefabricated EVD cases and 4/11 (36.4%) handmade EVD cases (p = 0.51), and replacement was required in 5/12 versus 3/11 cases (p = 0.47). In multivariable logistic regression, improvised EVD use was not significantly associated with CNS infection (aOR = 0.70; 95% CI: 0.07–6.63). In the literature review (7 publications; 317 patients), handmade EVDs were assembled using accessible materials (e.g., feeding tubes and urinary bags), with costs ranging from <US$5 to €20 versus ~€485 for commercial devices, and reported heterogeneous but broadly comparable complication profiles. Including our cohort, the total evidence base comprised 340 patients. Handmade EVDs appear feasible and substantially less costly than prefabricated systems. In this small retrospective cohort, we did not detect a clear signal of increased infection or replacement compared with commercial EVDs, but estimates were imprecise and do not establish equivalence. Handmade systems may serve as a temporary bridging option when commercial kits are unavailable, pending prospective validation and standardized protocols.